Home > Boards > US Listed > Biotechs > Avita Medical Ltd. (RCEL)

John,You make some very good points here. Speaking

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Hezekia Member Profile
 
Followed By 1
Posts 64
Boards Moderated 0
Alias Born 11/14/19
160x600 placeholder
AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati... Business Wire - 6/1/2020 9:28:00 PM
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference Business Wire - 5/21/2020 4:01:00 PM
AVITA Medical to Participate at Oppenheimer's MedTech Summit Business Wire - 5/13/2020 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/12/2020 11:00:49 AM
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &... Business Wire - 5/11/2020 4:31:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/11/2020 12:22:49 PM
AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin... Business Wire - 5/11/2020 11:47:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2020 2:14:54 PM
AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 4/29/2020 1:10:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/20/2020 5:25:55 PM
AVITA Medical Announces Intention to Redomicile to the United States of America Business Wire - 4/20/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2020 6:01:04 AM
AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update Business Wire - 4/6/2020 8:00:00 AM
RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online Business Wire - 4/1/2020 8:35:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries Business Wire - 3/4/2020 4:01:00 PM
AVITA Medical to Attend the 2020 BTIG Healthcare Conference Business Wire - 3/3/2020 4:05:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction Business Wire - 3/2/2020 10:21:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/19/2020 4:28:21 PM
AVITA Medical Half-Year Financial Report for Fiscal 2020 Business Wire - 2/19/2020 1:04:00 AM
AVITA Medical to Present at the Cowen 40th Annual Health Care Conference Business Wire - 2/11/2020 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/3/2020 12:28:14 PM
AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 1/30/2020 7:38:00 PM
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL Sy... Business Wire - 12/29/2019 6:49:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/6/2019 6:02:01 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2019 4:39:02 PM
Hezekia   Monday, 04/27/20 12:04:51 PM
Re: JohnSamuel post# 5660
Post # of 5729 
John,

You make some very good points here. Speaking strictly for myself, my current "disappointment" is not based on Avita's product(s), or its longer-term future. In fact, I believe they have a great future.

My disappointment surrounds the coming reverse split (assuming they get the votes and nothing else stops it). While they gave some good reasons for the redomiciliation, and I'm not opposed to it, reverse splits almost always cause loss of value for current shareholders (as we've seen the last few trading days). Often times that loss can become significant . How necessary is a reverse split - particularly during this challenging time? I'm just not sure I buy into this aspect of the change. I'm also very puzzled by the complete lack of any word on Japanese approval. This was supposed to have taken place by February (according to previous PR's). I realize that the CV pandemic likely has been the reason for delay, but have not received an answer to repeated questions I've asked the company about this topic.

Hopefully all of this will be moot a couple of years from now and Avita will be thriving.

Lastly - on a somewhat humorous note - I believe it's Pediatric "scalds" that they are in pivotal trials for, rather than Pediatric skulls. Don't believe RCEL is intended for bones.

JMHO


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist